Advertisement

ASCO 2022: Measurable Residual Disease Testing as Prognostic Tool in Acute Myeloid Leukemia
Posted: 06/13/2022 | By: Kayci Reyer

Question 1 of 5

In some patients with acute myeloid leukemia, measurable residual disease is associated with:

Choose 1

A
Increased risk of relapse and decreased risk of death
B
Decreased risk of relapse and decreased risk of death
C
Decreased risk of relapse and increased risk of death
D
Increased risk of relapse and increased risk of death

CategoriesView All Quizzes

Tumor Type


Additional Topics



Conference Coverage